RJFSA
PCRX icon

Raymond James Financial Services Advisors’s Pacira BioSciences PCRX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,713
Closed -$229K – 3317
2023
Q2 		$229K Sell
5,713
-69
-1% -$2.85K ﹤0.01% 2835
2023
Q1 		$236K Buy
+5,782
New +$230K ﹤0.01% 2793
2022
Q4 		– Sell
-4,749
Closed -$253K – 3348
2022
Q3 		$253K Buy
4,749
+810
+21% +$45K ﹤0.01% 2692
2022
Q2 		$230K Sell
3,939
-500
-11% -$32.8K ﹤0.01% 2788
2022
Q1 		$339K Buy
+4,439
New +$296K ﹤0.01% 2630
2021
Q3 		– Sell
-3,759
Closed -$228K – 3385
2021
Q2 		$228K Sell
3,759
-1,544
-29% -$97.7K ﹤0.01% 2922
2021
Q1 		$372K Buy
5,303
+1,224
+30% +$87.4K ﹤0.01% 2483
2020
Q4 		$244K Sell
4,079
-303
-7% -$17.7K ﹤0.01% 2585
2020
Q3 		$263K Sell
4,382
-2,108
-32% -$122K ﹤0.01% 2356
2020
Q2 		$341K Sell
6,490
-357
-5% -$14.9K ﹤0.01% 2159
2020
Q1 		$230K Buy
6,847
+884
+15% +$36.7K ﹤0.01% 2002
2019
Q4 		$270K Buy
+5,963
New +$253K ﹤0.01% 2386
2019
Q3 		– Sell
-5,361
Closed -$233K – 2909
2019
Q2 		$233K Buy
+5,361
New +$228K ﹤0.01% 2438
2019
Q1 		– Sell
-5,602
Closed -$241K – 2853
2018
Q4 		$241K Buy
5,602
+610
+12% +$28.5K ﹤0.01% 2139
2018
Q3 		$245K Buy
+4,992
New +$216K ﹤0.01% 2395

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Raymond James Financial Services Advisors's PCRX Position: Q3 2023 in Review

Raymond James Financial Services Advisors sold out of Pacira BioSciences (PCRX) in Q3 2023, closing a stake of 5,713 shares — an estimated $229K sold.

Raymond James Financial Services Advisors first reported a position in PCRX in Q3 2018 and held it in 15 quarters. The position peaked at $372K in Q1 2021. 261 funds tracked by Wall St. Rank hold PCRX as of Q3 2023.

  • Raymond James Financial Services Advisors reported no remaining Pacira BioSciences position as of Q3 2023 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 5,713 Pacira BioSciences shares in Q3 2023, an estimated $229K.
  • Raymond James Financial Services Advisors first reported a position in Pacira BioSciences in Q3 2018 and held it in 15 quarters.
  • Raymond James Financial Services Advisors's Pacira BioSciences position peaked at $372K in Q1 2021.
  • 261 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.